This inventor holds 1 USPTO granted patent. Top assignee: Sinntaxis Ab. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: **Carin Sjölund: Innovator in Neuropharmacology**
Introduction
Carin Sjölund is a notable inventor based in Malmo, Sweden, recognized for her contribution to neuropharmacology. With a focus on improving treatments for brain injuries, her innovative work has the potential to impact the lives of many.
Latest Patents
Carin holds a patent for "Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages." This patent involves the use of negative allosteric modulators (NAMs) targeting the metabotropic glutamate receptor 5 (mGluR5). This research is particularly relevant for treating brain damage arising from conditions such as stroke.
Career Highlights
Carin’s career has been marked by her dedication to developing therapeutic solutions for neurological conditions. Her innovative approach to pharmacology demonstrates her commitment to advancing medical science and improving patient outcomes.
Collaborations
At Sinntaxis Ab, Carin collaborates with talented professionals such as Tadeusz Wieloch and Kerstin Beirup. Together, they contribute to groundbreaking research that aims to address significant medical challenges in brain health.
Conclusion
Carin Sjölund exemplifies the spirit of innovation in the field of neuropharmacology. Her patent and collaborative efforts enhance the prospects for effective treatments of brain injuries, showcasing her integral role in advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile